2026-05-08T17:04:54.456Z / 路透社
作者：艾哈迈德·阿布勒埃宁与贾里特·伦肖
2026年5月8日 世界标准时间17:04，2小时前更新
美国华盛顿特区，2026年1月22日，苏珊·B·安东尼反堕胎美国分会主席玛乔丽·丹恩弗勒在华盛顿美国卫生与公众服务部外举行的抗议活动中发言，呼吁特朗普政府禁止堕胎药。路透社/亚伦·施瓦茨/档案照片 购买授权，将在新标签页打开
华盛顿，5月8日（路透社）——反堕胎活动人士将于周五会见白宫官员。与此同时，该运动内部的不满情绪日益高涨，他们认为唐纳德·特朗普总统在推进关键优先事项方面行动不够积极，包括新增堕胎服务限制以及加强现有政策的执行力度。
此次会议召开前数日，颇具影响力的苏珊·B·安东尼反堕胎美国分会主席玛乔丽·丹恩弗勒告诉《华尔街日报》，自2022年最高法院推翻“罗伊诉韦德案”以来，美国的堕胎数量有所上升，并补充称“特朗普是问题所在”。
开启您的晨间法律资讯订阅
通过《每日案卷》通讯将最新法律新闻直接发送至您的收件箱。在此注册。
广告 · 滚动继续阅读
这些事态发展凸显出特朗普与部分反堕胎运动群体之间日益紧张的关系。这些群体在特朗普首次总统竞选期间曾是他最坚定的政治盟友之一。
尽管活动人士称赞特朗普通过任命最高法院大法官帮助推翻了“罗伊诉韦德案”，但一些团体表示，本届政府并未采取积极的联邦行动来限制堕胎服务，包括对堕胎药米非司酮实施更严格的限制，以及打击在线售药商家。
白宫发言人艾莉森·舒斯特为政府的记录进行了辩护。
“特朗普总统是美国历史上最支持生命、最支持家庭的总统，他的政府已经宣布了一系列大胆举措，以保护生命并维护美国人的基本自由，包括终止美国对外的堕胎资助，”舒斯特在一份声明中说道。
广告 · 滚动继续阅读
苏珊·B·安东尼反堕胎美国分会未回应置评请求。
研究组织古特马赫研究所的数据显示，自2022年最高法院推翻其赋予全国堕胎合法权利的裁决以来，堕胎数量有所上升。2025年临床医生实施的堕胎数量估计达112.6万例，为2009年以来最高，这主要得益于堕胎药的使用范围扩大，目前在堕胎合法的州，堕胎药占堕胎案例的65%。
近几个月来，随着共和党议员和反堕胎团体敦促食品药品监督管理局重新审视米非司酮的安全规定，施压行动愈演愈烈。这种药物被用于美国一半以上的堕胎手术。参议院共和党人于3月启动了对堕胎药制造商的调查，并敦促FDA打击该药物的在线销售。
此前一系列关于邮寄获取米非司酮的法院裁决，使得围绕堕胎药物的辩论升级。
本周，美国最高法院在诉讼继续进行期间，暂时恢复了通过远程医疗和邮寄方式获取该药物的渠道。
贾里特·伦肖报道；桑吉夫·米格拉尼编辑
我们的报道准则：路透社信托原则
Anti-abortion activists meet White House officials amid frustration over Trump agenda
2026-05-08T17:04:54.456Z / Reuters
By Ahmed Aboulenein and Jarrett Renshaw
May 8, 2026 5:04 PM UTC Updated 2 hours ago
President of Susan B. Anthony Pro-Life America, Marjorie Dannenfelser, speaks during a protest to call on the Trump administration to ban the abortion pill, outside the U.S. Department of Health and Human Services (HHS) in Washington, D.C., U.S., January 22, 2026. REUTERS/Aaron Schwartz/File Photo Purchase Licensing Rights, opens new tab
WASHINGTON, May 8 (Reuters) – Anti-abortion activists will meet with White House officials on Friday as frustration grows within the movement that President Donald Trump has not moved aggressively enough to advance key priorities, including new restrictions on abortion access and stronger enforcement of existing policies.
The meeting comes just days after Marjorie Dannenfelser, the influential president of Susan B. Anthony Pro-Life America, told the Wall Street Journal that abortions have risen in the United States since the Supreme Court overturned Roe v. Wade in 2022, adding that “Trump is the problem.”
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
The developments underscore growing tensions between Trump and parts of the anti-abortion movement that were among his strongest political allies during his first presidential campaign.
While activists credit Trump for helping overturn Roe v. Wade through his Supreme Court appointments, some groups say the administration has not followed through with aggressive federal action to curb abortion access, including tighter restrictions on the abortion pill mifepristone and enforcement against online pill distributors.
White House spokeswoman Allison Schuster defended the administration’s record.
“President Trump is the most pro-life and pro-family president in American history, and his Administration has announced a series of bold actions to safeguard life and uphold Americans’ fundamental freedoms, including ending federal funding of abortion abroad,” Schuster said in a statement.
Advertisement · Scroll to continue
Susan B. Anthony Pro-Life America didn’t respond to a request for comment.
Data from the Guttmacher Institute, a research group, show abortions have risen since the Supreme Court’s 2022 ruling overturning its decision making abortion legal nationwide, with an estimated 1,126,000 provided by clinicians in 2025, the highest since 2009, driven largely by the expanded use of abortion pills, which now account for 65% of abortions in states where the procedure is legal.
The pressure campaign has intensified in recent months as Republican lawmakers and anti-abortion groups push the Food and Drug Administration to revisit safety rules surrounding mifepristone, which is used in more than half of U.S. abortions. Senate Republicans in March launched a probe into abortion pill manufacturers and urged the FDA to crack down on online sales of the drug.
The debate over abortion medication has escalated following a series of court rulings over mail-order access to mifepristone.
This week, the U.S. Supreme Court temporarily restored access to the drug through telemedicine and mail delivery while litigation continues.
Reporting By Jarrett Renshaw; Editing by Sanjeev Miglani
Our Standards: The Thomson Reuters Trust Principles.
发表回复